Skip page top navigationFDA Logo--links to FDA home page Logo of and Link to start page of Office of Regulatory Affairs, U.S. Food and Drug Administration U.S. Food and Drug Administration Office of Regulatory Affairs HHS Logo and link to Department of Health and Human Services website

FDA Home Page | Federal-State | Import Program | Compliance | Inspection | Science | ORA Search

Compliance Policy Guides Manual
Chapter 4 
Human Drugs - Contents

Updated: 06-20-2006

Sub Chapter

400 - General 450 - 457 OTC
410 - Bulk Drugs 460 - Pharmacy Issues
420 - Compendial /Test Requirements 470 - Post Approval Issues
425 - Computerized Drug Processing 480 - Stability/Expiration
430 - Labeling and Repackaging 490 - Validation
435 - Medical Gases  
440 - 448 New Drugs

Sub Chapter 400 - General

400.100 Drugs, Human - Failure to Register CPG 7132.07

400.200 Consistent Application of CGMP Determinations CPG 7132.12

400.210 Radiofrequency Identification Feasibility Studies and Pilot Programs

400.325 Candy "Pills" Representation as Drug CPG 7132.04

400.335 Fructose-Containing Drugs CPG 7123b.02

400.400 Conditions Under Which Homeopathic Drugs May be Marketed
CPG 7132.15

400.500 Identical or Similar Product Names CPG 7132b.14

400.600 Drugs - Declaration of Quantity of Active CPG 7132.03

400.700 Drug Product Entries in Periodic Publications CPG 7132b.17

400.800 Collection and Charitable Distribution of Drugs CPG 7132.08

400.900 Class I Recalls of Prescription Drugs CPG 7132.01

Sub Chapter 410 - Bulk Drugs

410.100 Finished Dosage Form Drug Products in Bulk Containers - Applications of Current Good Manufacturing Practice Regulations CPG 7132a.06

Sub Chapter 420 - Compendial /Test Requirements

420.100 Adulteration of Drugs Under Section 501(b) and 501(c) of the Act. Direct Reference Seizure Authority for Adulterated Drugs Under Section 501(b) CPG 7132a.03

420.200 Compendium Revisions and Deletions CPG 7132.02

420.300 Changes in Compendial Specifications and NDA CPG 7132c.04

420.400 Performance of Tests for Compendial Requirements on Compendial Products CPG 7132.05

420.500 Interference with Compendial Tests CPG 7132a.01

Sub Chapter 425 - Computerized Drug Processing

425.100 Computerized Drug Processing; CGMP Applicability to Hardware and Software CPG 7132a.17

425.200 Computerized Drug Processing; Vendor Responsibility CPG 7132a.12

425.300 Computerized Drug Processing; Source Code for Process Control Application Programs CPG 7132a.15

425.400 Computerized Drug Processing; Input/Output Checking CPG 7132a.07

425.500 Computerized Drug Processing; Identification of "Persons" on Batch Production and Control Records CPG 7132a.08

Sub Chapter 430 - Labeling and Repackaging

430.100 Unit Dose Labeling for Solid and Liquid Oral Dosage Forms CPG 7132b.10

430.200 Repacking of Drug Products - Testing/Examination under CGMPs
CPG 7132.13


430.300 Labeling Shipping Containers of Drugs CPG 7132b.13

430.400 Urinary Preparations - Misbranding - Lack of Rx Legend and Claims
CPG 7132b.04

Sub Chapter 435 - Medical Gases

435.100 Compressed Medical Gases - Warning Letters for Specific Violations Covering Liquid and Gaseous Oxygen CPG 7132a.16

Sub Chapter 440 - 448 New Drugs

440.100 Marketed New Drugs Without Approved NDAs CPG 7132c.02
06/20/2006 This CPG supersedes section 440.100, Marketed New Drugs Without Approved NDAs or ANDAs (CPG 7132c.02)

442.100 New Drugs - Export CPG 7132c.01

444.100 Recovery of Investigational New Drugs from Clinical Investigators CPG 7132c.05

446.100 Regulatory Action Regarding Approved New Drug and Antibiotic Drug Products Subjected to Additional Processing or other Manipulations CPG 7132c.06

448.100 Reconditioning of New Drugs Which Do Not Have Approved NDAs/ANDAs CPG 7132c.03

Sub Chapter 450 - 457 OTC

450.100 CGMP Enforcement Policy - OTC vs Rx Drugs CPG 7132.10

450.200 Drugs - General Provisions and Administrative Procedures for Recognition as Safe and Effective CPG 7132b.15

450.300 OTC Drugs - General Provisions and Administrative Procedures for Marketing Combination Products CPG 7132b.16

450.400 Labeling and Distribution of OTC Drugs in Vending Machines CPG 7132b.06

450.500 Tamper-Resistant Packing Requirements for Certain Over-the-Counter (OTC) Human Drug Products CPG 7132a.17

450.550 Control and Accountability of Labeling Associated with Tamper-Resistant Packaging of Over-the-Counter Drug Products CPG 7132.14

454.100 OTC Ear Drop Preparations CPG 7132b.01

455.100 Inert Glandular Preparations *(OTC)*, Inadequate Full Disclosure and Claims CPG 7132b.12

456.100 Non-Rx Drugs Anti-Obesity Preparations CPG 7132b.05

457.100 Pangamic Acid and Pangamic Acid Products Unsafe for Food and Drug Use CPG 7121.01

Sub Chapter 460 - Pharmacy Issues

460.100 Hospital Pharmacies - Status as Drug Manufacturer CPG 7132.06

460.200 Pharmacy Compounding (Reissued 05/29/2002)

460.300 Return of Unused Prescription Drugs to Pharmacy Stock CPG 7132.09

460.400 Computerized Prescription Recordkeeping by Pharmacies CPG 7132b.09

460.425 Prescription Status when Telephoned to Recording Machine CPG 7132b.08

460.450 Status of Mail-Order Filling of Prescriptions CPG 7132b.07

460.500 Prescription Drugs for Ship's Medicine Chests CPG 7132.11

460.600 Content Uniformity Testing of Tablets and Capsules CPG 7132a.14

460.700 Controlled Release Dosage Form Drugs - Rate of Release of Active Ingredients CPG 7132a.02 (Revoked - Obsolete - Superseded by 21 CFR 310.502(a)(14) )


460.800 Parametric Release - Terminally Heat Sterilized Drug Products CPG 7132a.13

Sub Chapter 470 - Post Approval Issues

470.100 Orders for Post-Approval Record Reviews CPG 7132c.07

Sub Chapter 480 - Stability/Expiration

480.100 Requirements for Expiration Dating and Stability Testing
CPG 7132a.04

480.200 Expiration Dating of Unit Dose Repackaged Drugs CPG 7132b.11

480.300 Lack of Expiration Date of Stability Data CPG 7132a.10

Sub Chapter 490 - Validation

490.100 Process Validation Requirements for Drug Products and Active Pharmaceutical Ingredients Subject to Pre-Market Approval CPG 7132c.08

Hypertext formatted 04/18/2001 tmc